Trubion Pharmaceuticals Inc. (TRBN)

TRBN is defunct.

TRBN Related Articles more »

Merger Arbitrage Mondays: November 01, 2010

Asif Suria • Mon, Nov 1, 2010 • Comment!
Merger Arbitrage Mondays: August 16, 2010

Asif Suria • Mon, Aug 16, 2010 • Comment!
Biotech's Slow Week Gets Stirred by a Few Smaller Deals

The Burrill Report • Sun, Aug 15, 2010 • 1 Comment
Emergent Seeks Diversity in Trubion Purchase

EP Vantage • Sun, Aug 15, 2010 • Comment!
Pfizer Dumps Arthritis Drug After Trial Results Fail to Excite

The Burrill Report • Thu, Jun 17, 2010 • Comment!
13 Biotechs to Watch for at Hematology Conference

Michael Becker • Mon, Nov 30, 2009 • Comment!
Stock Watch: CSUH.OB, MHTX.OB, BIEL.PK, SPHRY.PK

VFC's Stock House • Sun, Sep 13, 2009 • 14 Comments
Readers Ask: Sponge Tech, Telanetix, Trubion Pharmaceuticals

VFC's Stock House • Thu, Sep 10, 2009 • 21 Comments
Exiting Facet Biotech on Biogen's Offer

ValueHuntr • Mon, Sep 7, 2009 • 2 Comments
Several Promising Deals for Biotech

The Burrill Report • Sun, Aug 30, 2009 • 1 Comment

TRBN Latest Transcript more »

Trubion Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript

Thu, Nov 20, 2008
Popular searches: wyeth, million, data, due, phase, results, september, third, tru-015, tru-016.

Earlier TRBN transcripts

TRBN Cramer more »

Currently, there are no Cramer articles on TRBN.

TRBN Instablog posts more »

Last Week's Top Performers for the BioPharma Market

Sat, Aug 14, 2010 • BioPharma Investor • 1 Comment
Three Biotech Trades for EULAR (IMMU, RDEA, TRBN)

Tue, Jun 8, 2010 • Andrew Nava • Comment!
Deals return to the biotech space

Fri, Sep 4, 2009 • Sam Subramanian • Comment!

Company Description

Trubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of novel protein therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. Our mission is to develop a variety of first-in-class and best-in-class product candidates customized in an... More

Country: United States